Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy

• Francesca Ferraro,
• Agata Gruszczynska,
• Marianna B. Ruzinova,
• Christopher A. Miller,
• Mary Elizabeth Percival,
• Geoffrey L. Uy,
• Iskra Pusic,
• Meagan A. Jacoby,
• Mathew J. Christopher,
• Miriam Y. Kim,
• Peter Westervelt,
• Amanda F. Cashen,
• Mark A. Schroeder,
• John F. DiPersio,
• Camille N. Abboud,
• Lukas D. Wartman,
• Feng Gao,
• Daniel C. Link,
• Timothy J. Ley,
• John S. Welch

Affiliations

Francesca Ferraro

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Agata Gruszczynska

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Marianna B. Ruzinova

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri 63110

Christopher A. Miller

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Mary Elizabeth Percival

Department of Internal Medicine, Division of Hematology, University of Washington School of Medicine, Seattle, Washington 98195; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109

Geoffrey L. Uy

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Iskra Pusic

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Meagan A. Jacoby

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Mathew J. Christopher

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Miriam Y. Kim

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Peter Westervelt

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Amanda F. Cashen

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Mark A. Schroeder

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

John F. DiPersio

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Camille N. Abboud

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Lukas D. Wartman

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Feng Gao

Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri 63110

Daniel C. Link

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

Timothy J. Ley

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110

John S. Welch

Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110